IDO1 and breast cancer: Independent studies have stated that miR-200c-3p overexpression resulted in a downregulation of PD-L1 and IDO1 in adipose-derived mesenchymal stem cells, and decreased PD-L1 levels in ovarian cancer and breast cancer cells [40–42].